ClinicalTrials.gov
ClinicalTrials.gov Menu

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01353937
Recruitment Status : Withdrawn (Never Activated)
First Posted : May 16, 2011
Last Update Posted : March 4, 2016
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : March 2016
  Estimated Study Completion Date : September 2016